rs11362 — DEFB1 G-20A

DEFB1 G-20A — Your First Line of Mucosal Defense

The surfaces lining your gut, mouth, and airways are under constant microbial assault. Beta-defensin 1 (hBD-1)¹¹ Beta-defensin 1 (hBD-1)
a small cationic antimicrobial peptide of 36 amino acids, constitutively expressed by epithelial cells throughout the gastrointestinal and urogenital tracts is one of the body's key innate antimicrobial peptides, continuously secreted by epithelial cells to maintain the delicate boundary between host tissue and the microbial world. Unlike most defensins that are induced by infection or inflammation, hBD-1 is [constitutively expressed | meaning it is always present as a standing guard, rather than being activated only when infection is detected] — it functions as a permanent sentinel in mucosal surfaces.

The G-20A variant (rs11362) sits in the 5' untranslated region (5' UTR)²² 5' untranslated region (5' UTR)
the region of mRNA before the protein-coding sequence begins, which regulates how efficiently the gene is translated into protein of the DEFB1 gene on chromosome 8. Because DEFB1 is transcribed from the minus strand, the "G-20A" notation used in research literature corresponds to a C-to-T change on the plus strand reported by genome sequencing. The T allele (coding-strand A) is carried by approximately 44% of Europeans and reduces hBD-1 expression, weakening mucosal antimicrobial defense.

The Mechanism

The 5' UTR of a gene controls how efficiently its mRNA is translated into protein. The rs11362 variant alters mRNA secondary structure³³ alters mRNA secondary structure
different DEFB1 mRNAs fold in patterns that are haplotype- and length-dependent, potentially driving changes in peptide expression dynamics in ways that reduce translation efficiency. This region also contains putative NF-kappaB binding sites⁴⁴ putative NF-kappaB binding sites
NF-kappaB is a master transcription factor for immune response genes; altered binding reduces defensin transcription, and the variant may impair transcription factor recruitment.

Direct evidence of reduced expression comes from a study of 754 adolescents measuring salivary hBD-1 protein⁵⁵ study of 754 adolescents measuring salivary hBD-1 protein
CC genotype: 4.12 ng/mL; CT genotype: 2.77 ng/mL; TT genotype: 2.32 ng/mL. The TT genotype produces roughly 44% less hBD-1 protein than CC — a substantial reduction in antimicrobial peptide output at mucosal surfaces. GTEx data further confirm that the risk genotype associates with lower DEFB1 mRNA expression across multiple tissues⁶⁶ risk genotype associates with lower DEFB1 mRNA expression across multiple tissues
including aorta, coronary artery, and heart tissue.

The Evidence

Colonic Crohn's disease. A case-control study of 190 Crohn's patients and 95 controls⁷⁷ A case-control study of 190 Crohn's patients and 95 controls
Kocsis et al. studied Hungarian patients with detailed disease localization phenotyping found the heterozygous genotype at 60% frequency among patients with colonic Crohn's versus 39% in controls (OR 2.39). Notably, no association was found with ileal Crohn's disease, which is consistent with the biology: hBD-1 is constitutively expressed in colonic epithelium⁸⁸ hBD-1 is constitutively expressed in colonic epithelium
unlike alpha-defensins which predominate in ileal Paneth cells, beta-defensin 1 is the primary constitutive defensin of the colon, so reduced expression would specifically compromise colonic defense.

Dental caries. A meta-analysis of rs11362 and dental caries⁹⁹ meta-analysis of rs11362 and dental caries
Hatipoglu and Saydam, 2020, pooling multiple case-control studies found that TT homozygotes have 7-fold higher caries risk compared to CC, with the dominant model showing OR 3.11 (95% CI 1.18-8.21, p=0.022). A separate study found that carrying a copy of the variant allele increased DMFT/DMFS scores more than five-fold¹⁰¹⁰ carrying a copy of the variant allele increased DMFT/DMFS scores more than five-fold
DMFT = Decayed, Missing, and Filled Teeth index, a standard measure of caries burden. The mechanism is straightforward: reduced hBD-1 in saliva allows cariogenic bacteria like Streptococcus mutans to colonize tooth surfaces more effectively.

Periodontitis. Despite the oral health connection, a meta-analysis of 7 case-control studies¹¹¹¹ meta-analysis of 7 case-control studies
approximately 1,500 participants, analyzing allelic, dominant, and recessive models found no significant association between rs11362 and chronic periodontitis (allelic OR 0.86, 95% CI 0.61-1.20). Periodontitis is driven more by inflammatory response than by direct antimicrobial defense, which may explain why a defensin expression variant has less impact.

Other associations. The variant has also been linked to HIV-1 susceptibility in Mexican women¹²¹² HIV-1 susceptibility in Mexican women
-20A allele OR 1.60, 95% CI 1.06-2.40 and to coronary artery disease risk with reduced cardiac hBD-1 expression¹³¹³ coronary artery disease risk with reduced cardiac hBD-1 expression
2024 case-control study of 219 CAD patients vs 522 controls, reflecting the broad antimicrobial and immunomodulatory role of beta-defensin 1 across tissues.

Practical Implications

Beta-defensin 1 is a [zinc-dependent antimicrobial peptide | defensins use cysteine-coordinated zinc binding for structural stability and antimicrobial function]. Zinc is essential both for defensin protein folding and for broader innate immune signaling. Carriers of the reduced-expression genotype should ensure adequate zinc status, as deficiency would compound the genetic reduction in hBD-1 output.

Vitamin D signaling upregulates antimicrobial peptide expression¹⁴¹⁴ upregulates antimicrobial peptide expression
1,25-dihydroxyvitamin D3 induces cathelicidin and beta-defensin gene expression through VDR-mediated pathways in epithelial cells through VDR-mediated pathways. While the best-characterized targets are cathelicidin (LL-37) and beta-defensin 2, the broader defensin family benefits from adequate vitamin D status. For individuals with genetically reduced DEFB1 expression, optimizing vitamin D may partially compensate by upregulating other antimicrobial peptides in the same mucosal compartments.

Lactoferrin¹⁵¹⁵ Lactoferrin
an iron-binding glycoprotein naturally present in mucosal secretions, saliva, and breast milk works synergistically with defensins as part of the mucosal innate defense system. Oral lactoferrin supplementation enhances mucosal barrier function and antimicrobial activity, complementing reduced defensin output.

Interactions

rs11362 is one of three functional 5' UTR variants in DEFB1 that form haplotypes affecting expression. The others are rs1799946 (G-52A) and rs1800972 (C-44G)¹⁶¹⁶ rs1799946 (G-52A) and rs1800972 (C-44G)
these three SNPs in the DEFB1 5' UTR create haplotypes with distinct mRNA folding patterns and transcription factor binding affinities. The rs1800972 GG genotype appears protective for Crohn's disease (OR 3.37 protective), while rs11362 and rs1799946 confer risk. Combined haplotypes show stronger effects than individual variants — the ACA haplotype (coding strand) was associated with 5.82-fold increased HIV-1 susceptibility.

In the context of Crohn's disease, DEFB1 variants may compound with NOD2 (rs2066844) mutations¹⁷¹⁷ NOD2 (rs2066844) mutations
NOD2 controls Paneth cell defensin production in the ileum, while DEFB1 governs colonic defensin expression. A patient carrying both DEFB1 risk variants (reduced colonic defensin) and NOD2 variants (reduced ileal defensin) would have compromised antimicrobial peptide defense along the entire intestinal tract, substantially increasing inflammatory bowel disease susceptibility.